Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer
Gupta et al. demonstrate that targeting isoform-specific TGFβ leads to an increase in the anti-tumor response when compared to pan-TGFβ inhibition, due to enhanced CD8 T cell function. The authors also report that combining TGFβ inhibition with immune checkpoint blockade results in improved tumor co...
Guardado en:
Autores principales: | Aditi Gupta, Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O. Michel, Aliya Holland, Luis Felipe Campesato, Jacques van Snick, Catherine Uyttenhove, Gerd Ritter, Jedd D. Wolchok, Taha Merghoub |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed988a10eff742c391e7da0374286113 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
por: Luis Felipe Campesato, et al.
Publicado: (2020) -
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Yi Wang, et al.
Publicado: (2021) -
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
por: Dmitriy Zamarin, et al.
Publicado: (2017) -
IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling
por: Gang Xue, et al.
Publicado: (2019) -
Single-molecule, full-length transcript isoform sequencing reveals disease-associated RNA isoforms in cardiomyocytes
por: Chenchen Zhu, et al.
Publicado: (2021)